This report describes details of the requirements and practical procedures for quantitative assessments of biological functional parametric images of the brain using 123 I-labeled tracers and clinical SPECT systems. With due understanding of the physics and the biological background, this is considered achievable even under clinical environments, provided that data are appropriately acquired, processed, and analyzed. This article discusses how potential hurdles have been overcome for quantitatively assessing quantitative functional parametric images in clinical settings, with successful examples that provided additional clinically useful information.
Introduction
Current clinical practice using SPECT relies largely on the interpretation of qualitative images reflecting physiologic functions. However, a quantitative analysis could provide further information to assist in the interpretation of disease status and treatment decisions. Methodological progress has made a quantitative determination of physiological functions through imaging feasible for brain scans, including parameters like the cerebral blood flow (CBF) and cerebral flow reactivity (CFR) after pharmacological vasodilatation and also neuro-receptor functions and others.
The usefulness of such data has generally been limited to research due to the logistical complexity of quantitative examinations. Extensive work has then been carried out to make quantitative study doable in clinical environments, and some relevant study protocols are today generally accepted in clinical institutions in Japan.
Statistics show that 20 % of all SPECT clinical scans, namely approximately 20,000 scans annually, are carried out for the brain, mostly on patients with neurological (67 %) and cerebral vascular diseases (33 %), which is a much larger number than in other countries. Quantitative assessments of CBF (mostly with CFR) using 123 I-iodoamphetamine (IMP) comprise 5.6 % of all SPECT scans. Further, software programs assisting in the diagnosis are utilized with most brain scans, employing statistical analysis such as the 3D-SSP of Minoshima and others [1] [2] [3] [4] [5] . 123 I-IMP and other 123 I-labeled tracers such as 123 I-iomazenil and 123 I-FP-CIT are approved for clinical use and can be employed in a quantitative analysis for demonstrating biological parametric images. Attenuation correction and scatter correction are necessary factors when conducting quantitative studies. Additional unique error of septal penetration is present when employing 123 I-labeled radiopharmaceuticals.
With SPECT scans there is the advantage over PET in the availability of the necessary scanner in clinical institutions. Availability of radiopharmaceuticals is another factor which would make conducting of such clinical research simple and straightforward. Standardization of the techniques is essential to be able to generate quantitative functional images that are consistent among institutions and SPECT scanners. This is important particularly when applying diagnosis-assisting software programs, to ensure consistent results independent of the SPECT devices installed at different institutions. The ability to refer to and compare results from different institutions or databases created at different institutions also requires that quantitative and reproducible results are needed.
This article describes how an integrated system was developed to enable a quantitative assessment of images of biological functions consistent among institutions in clinical setting with 123 I-labeled radiopharmaceuticals. To achieve this we describe the physics and technical background needed for the quantitation. Application and verification of the developed software packages as clinical diagnostic tools, and how users have been supported, will also be discussed for 123 I-IMP, 123 I-IMZ, and 123 I-FP-CIT examinations.
Requirements for Quantitative Reconstructions in SPECT

Scatter Correction
It is commonly accepted that the scatter and attenuation occurring in an object are the two major error factors with SPECT, and these need to be compensated for in the quantitative imaging. One technique to estimate the scatter distribution is to acquire projection data for additional energy windows in addition to the main window that covers the main peak. Selecting two additional windows below and above the main peak, the so-called triple-energy window (TEW) [6] method, is a commonly applied technique, in which acquired counts of the lower and upper windows are subtracted from those of the main window, and the reconstruction is then performed using the scatter-subtracted projection data. An advantage of this technique is that the procedures automatically compensate for the photons penetrating the collimator (see below). An alternative approach is based on estimating the scatter from the scatteruncorrected reconstructed images using the attenuation coefficient distribution. A formulation like the Klein-Nishina formula is commonly applied to simulate the scatter projection for a given tracer distribution and is termed the single scatter simulation (SSS) method [7] . This calculation can also be performed by Monte Carlo simulation (MCS), where simplification is effective to accelerate the calculations and ensure minimal loss of accuracy [8] . One further simplified approach is also feasible, by referring to the emission and attenuation data available in the projection domain; this was originally proposed by Meikle et al. [9] and was further optimized for 99m Tc [10] , 201 Tl [11, 12] , and 123 I [13] in our group. A scatter fraction is empirically defined for a radioisotope as a function of the attenuation factor, which is then used to scale the simulated scatter distribution. This is the transmission-dependent convolution subtraction (TDCS) method and is applied to the geometric mean projection data. A number of verification studies have been carried out to ensure the accuracy of this method, but it must be noted that accuracy with the SSS and MCS theoretical methods is often limited because a number of factors are not taken into account. Our earlier work by a careful Monte Carlo simulation demonstrated that a non-negligible amount of scatter originates from outside objects such as the detector and scanner itself [14] and that this may be a source of errors if not taken into account.
With the software developed by our group for quantitative SPECT reconstruction (QSPECT), we have incorporated MCS-and TDCS-based scatter correction methods, and extensive work has shown support for this in the verification of the TDCS method for brain SPECT examinations. Due to the robustness and applicability when combined with other correction procedures, all results in the following will be with the TDCS scatter correction.
Septal Penetration in the Collimator
In addition to scatter and attenuation, 123 I has a further error arising from penetrating photons generated by high-energy gamma rays (>500 keV) emitted from the 123 I. These penetrating photons cause a down-scatter through the collimator and escaping photons from the scintillator, resulting in non-negligible levels of bias in the energy spectrum and therefore an offset in the projection data for the selected energy window (see Fig. 2 
.1).
Here it must be noted that the magnitude of the offset in the projection data due to the penetrating photons varies dependent on the collimator. With typical low-energy collimator sets, this represents a large amount, due to the thin walls of such collimators, while with typical 123 I-specifically designed collimator, the amount of offset is suppressed, due to thicker collimator walls. An example of a comparison of projection data obtained from two collimator sets of a typical low-energy high-resolution collimator (LEHR-para) and a 123 I-specific lowmedium-energy general-purpose collimator (LMEGP-para) from one vendor is shown in Fig. 2.2 . Collimator penetration is clearly visible with LEHR-para, but a b Fig. 2 .1 (a) Error sources which need to be compensated for in quantitative reconstruction of brain SPECT images, attenuation, scatter, and photon penetration. (b) Energy spectrum for 123 I in a typical LEHR collimator. The significantly high background signal is a source of errors, caused by the high-energy photons emitted by the 123 I itself not with LMEGP-para for a 123 I-syringe and also on the striatal brain phantom ( Fig. 2.2a ). This difference causes the different reconstructed images of uniform cylindrical phantoms ( Fig. 2.2b ). It is important to note that the counts are decreased in the center of the cylindrical phantom when the attenuation correction is not applied to the data obtained with LMEGP-para collimator, while the decreased counts in the center is not visible with LEHR-para. The TEW technique is effective to compensate for the penetrating high-energy photons. With the scatter correction performed by the TEW technique, these penetrating photons are automatically compensated for. This is practical and effective, but at the expense of increased statistical noise.
In the QSPECT software, the penetration component is determined empirically for a collimator, as an extension of the TDCS scatter correction, as described in an earlier report [13] .
Attenuation Correction
The Chang method [15] is the most common approach for attenuation correction (AC) in brain SPECT. This method utilizes an attenuation coefficient (μ) map a b In the projection data of the striatum phantom, striatum-to-whole brain ratio is also altered due to the penetrating photons. The reconstructed images also became different when not compensated. An appropriate correction procedure is important to compensate for the penetration for each set of the collimator which is commonly generated by detecting the head contours of the reconstructed images to which the AC is applied. The μ map can also be obtained from CT or from images of other modalities. The AC factors are then estimated for each pixel as an average over the 360 views with the attenuation coefficient (μ) map and is multiplied into the non-AC reconstructed images. The Chang method is empirical but the results are considered acceptable in most brain examinations. For the quantitative reconstruction, a uniform μ map is feasible if errors < 5 % are accepted in the deep parts of the brain. However, absolute values have to be carefully defined so as to make the pixel counts of the reconstructed images independent of the size of the object. This is also the case if a CT-based μ map is utilized in the reconstruction.
Attenuation Coefficient Map
Two possibilities are given to define the attenuation μ map in QSPECT software. One is to import externally generated attenuation μ maps, typically calculated from the Hounsfield unit (HU) images generated from a CT scan. Careful attention is needed to correct for the beam hardening effects when converting the attenuation map assessed with the continuous and rather low-energy photons to the quantitative HU and μ values corresponding to photons with single energy included in the energy window. Another possibility is to generate a homogeneous μ map by detecting the head contours. Extensive efforts have been made to provide the best accuracy in the head-contour detection algorithm, and a threshold was determined from the sinogram rather than the projection or the reconstructed images, and sine wave constraint was applied to the scatter-uncorrected data when defining the edge of the sinogram. Reconstruction was made for the filtered sinogram, and a threshold was applied again to determine the head contour, ensuring that an accurate head contour is generated. An empirically defined attenuation coefficient which effectively included the contribution of the bone value was then applied [13] . An attenuation coefficient map is utilized for the attenuation correction during the OSEM procedures and also for the scatter and penetration correction prior to the reconstruction if one utilizes one of the SSS, MCS, or TDCS methods for scatter correction. This attenuation coefficient map was utilized during the OSEM procedures as well as for the scatter and penetration correction prior to the reconstruction, by using the TDCS method as discussed earlier.
Implementation of the Collimator Aperture Model
It has been shown that implementation of a collimator aperture during the forward projection process on the three-dimensional domain makes the SPECT reconstruction more accurate [16] . Effects of this are increased, resulting in improved contrast and also suppression of statistical noise. The collimator aperture model shown in 
SPECT Reconstruction
Two methods are known to quantitatively reconstruct images in the brain SPECT which will be discussed here. The filtered back projection (FBP) method is the one and has been the standard for reconstruction. For the FBP, the scatter correction has to be applied to the projection data before the reconstruction, and TEW is a wellestablished technique compensating for the septal penetration during the reconstruction. An attenuation correction is performed after the reconstruction in most cases based on the Chang method with an edge detection technique to generate homogeneous μ maps. The use of CT-based attenuation coefficient images is also possible, but selection of the absolute μ values needs careful consideration, and there are no published reports on how consistent results can be obtained with this technique with different equipment arrangements. A preliminary study carried out in Europe [17] showed unacceptable levels of variation and inconsistencies among sites. The reasons for the inconsistencies are unknown, but it was suggested that further careful evaluations are needed to standardize the detailed procedures. Although the FBP approach is straightforward and has been considered a standard, the method is limited when implementing new functionality to maximize the accuracy and image quality.
An alternative reconstruction method for SPECT is based on the maximumlikelihood expectation maximization (MLEM) algorithm, in which images are calculated with iterative procedures. Attenuation can be implemented in the forward projection process, so that the calculated reconstructed images are corrected for attenuation. The ordered-subset maximum-likelihood expectation maximization (OSEM) method is often utilized to accelerate convergence, as will be discussed later in this article. It must be noted that the TEW-based scatter correction includes correction also for the penetration, while currently the existing simulation-based scatter correction method does not include a penetration correction, and thus requires further development.
The QSPECT software employs the OSEM approach. A schematic representation of the process of the reconstruction in QSPECT software is shown in Fig. 2.3 . Systematic errors arise due to neglecting higher μ values in the skull, but the effect is within AE5 % in the middle part of the brain and also in other areas outside the cerebral tissue [13] . The following three formulations were implemented in the program. Suitable formulation can then be selected to best fit each clinical protocol.
OSEM on 2D Domains for the Pre-scatter Corrected Geometric Mean Projection
The first formulation is essentially identical to the one also described in earlier studies [9] [10] [11] 13] . Reconstruction is performed for each two-dimensional tomographic slice, with the projection corrected for scatter before the reconstruction. The pixel counts of the reconstructed image λ nþ1 j are calculated from the counts of the previous image λ n j . The scatter compensated projection data by the TDCS method [18] was applied, and the formulation for the geometric mean projection data is given as follows:
Diagram illustrating the quantitative reconstruction protocol implemented in the QSPECT reconstruction software. The emission data are initially reconstructed with filtered back projection (top right image) to allow the brain outline to be determined and the μ map for the attenuation correction to be determined by assigning a uniform attenuation coefficient value of 0.1603 cm À1 to the detected brain volume. The μ map is forward projected to provide the attenuation projections for the scatter correction to calculate scatter-and penetration-compensated projection. The scatter correction is carried out using TDCS method; thus, the projection data becomes geometric mean data. Then, OSEM reconstruction is applied with the attenuation correction to generate the attenuation and scatter corrected images. The collimator aperture correction (APC) can also be applied in the reconstruction process using Eq. 
where y i is the count in the projection data corrected for the scatter and the collimator penetration, c ij is a factor for the contributions from the projection pixel to the image pixel, exp ÀμL i ð Þ is the net attenuation factor for each of the geometric mean projections. Note that the projection data has to be corrected before the reconstruction calculations, eg by the TDCS scatter correction.
OSEM on 3D Domains for the Pre-scatter Corrected Geometric Mean Projection
This formulation includes the collimator aperture correction, and the reconstruction is carried out nearly wholly in a three-dimensional domain. The scatter compensated projection data by the TDCS method [18] was applied, giving the formulation for the geometric mean projection data as follows:
where w ij represents the collimator dependent blurring of the spatial resolution shown in Fig. 2.4 . Note that the projection data has to be corrected for the scatter before the reconstruction calculations as in the eq. 2.1 in which y i is the geometric mean projection data already corrected for scatter by means of the TDCS method, and c ij represents the calculation of the geometric mean.
OSEM on 3D Domains Including the Scatter Correction Process
This formulation includes the scatter correction process during the reconstruction as follows:
The scatter projection at the i-th iteration, s i , has to be estimated at each iteration either by the SSS or MCS methods from the i-th reconstructed images. It is also possible to use the TEW-based scattered projection for s i . In QSPECT, an 
Calibration to Bq/mL
The QSPECT program is designed so that the pixel values correspond to the radioactivity concentration, the cps/mL. An experiment with a syringe filled with a 123 I-labeled radioactive pharmaceutical of known radioactivity gives a calibration factor to convert the pixel counts to the absolute radioactivity concentration which has units of Bq/mL. The accuracy of the absolute quantitation was AE 10 % for 123 I in uniform cylindrical phantoms provided that the diameter is less than 16 cm. For the future, this feature could be of use in internal dosimetry quantitation of radiotherapy agents such as 177 Lu peptides.
Dead Time Count Loss
The counting rate performance should be sufficiently high in clinical SPECT scanners, e.g., count losses <1 % up to a counting rate of 70 kcps. This would hold for 99m Tc and other commonly used SPECT radiopharmaceuticals, but may not in 123 I-labeled tracers. The true counting rate of the system could be much higher than the observed rate for the given main window, attributed to the incidence of a large amount of penetrating photons originated from the high-energy gamma rays (>500 keV). Particularly, low-energy dedicated collimators such as LEHR collimators can accept large amounts of penetrating photons, and there may be a significant counting loss at counting rates much below 70kcps. Errors could be mostly in phantom experiments but may be smaller in clinical scans. It is however important to confirm the maximum counting rate that maintains the linearity of the SPECT counts to the true radioactivity.
Phantom Experiments
A number of studies have been carried out to evaluate the adequacy of the QSPECT reconstruction programs. The experiments were on geometrically shaped phantoms such as cylindrical phantoms and also on phantoms simulating the cerebral blood flow distribution and striatum structure with realistic head contours and skull structures. These phantom experiments are useful in validating the reconstruction procedures and also to ensure quality control of the data acquisition procedures.
Uniform Cylindrical Phantom
The cylindrical phantom gives information of how uniform images are obtained for uniform distributions of radioactivity. Image homogeneity could be degraded by several factors in relation to inappropriate corrections for attenuation, to scatter and penetration, and also to the insufficient quality control. The quality control includes the procedures for adjusting and correcting for inhomogeneous sensitivity, mistuned position linearity, misaligned center of rotation, large attenuations in the head holder, and other factors. Experiments to confirm the homogeneity for uniform phantom are highly suggested to ensure that the regional activity quantitation is not suffered from one of error factors mentioned above. However, it should be noted that inappropriate definition of the head contour and inconsistently defined attenuation coefficient values in relation to the presence of the skull may not be evaluated from the uniform cylinder phantom experiment.
3D Brain Iida Phantom for CBF Quantitation
Geometrically shaped phantoms are limited in simulating realistic head contours, the presence of the bone and trachea, and also the realistic radioactivity distribution. Therefore, dedicated brain-simulating phantoms are often desired to evaluate the overall accuracy of reconstructed images in realistic situations. We have developed a three-dimensional brain phantom (Iida phantom) that simulates the CBF distribution in cortical gray matter, with bone, trachea, and realistic head contours [19] . As shown in Fig. 2 .5, accuracy of the QSPECT software can be evaluated by referring regional radioactivity concentration on the reconstructed images with those of design images of this phantom. This experiment would be useful if one wish to evaluate the accuracy of reconstructed images for multicenter clinical studies using SPECT techniques. Differences in the spatial resolution have to be assessed when comparing SPECT images acquired from different SPECT systems, because the differences in the spatial resolution causes different quantitative values due to the partial volume effect [20] . Hoffman 3D phantoms [21] was utilized to assess and to compensate for the different spatial resolution in the cerebral FDG uptake images acquired at different institutions using different PET systems on healthy volunteers [20] . The Iida brain phantom is also useful to evaluate and equalize the spatial resolution of SPECT images obtained from different sites and probably better suited to SPECT, due to its importance in the determination of head contour in SPECT scans. Yamauchi et al. [22] demonstrated that equalization of the spatial resolution significantly reduced the inter-institutional variation of the normal database of rest-and acetazolamide-CBF images among three institutions. The Iida brain phantom may be better suited than the 3D Hoffman phantom when one intends to assess attenuation or scatter-related variations among different PET/SPECT scanners.
Striatum Phantom for Dopamine Transporter Imaging
For dopamine transporter imaging using 123 I-FP-CIT, a phantom simulating the striatum uptake of 123 I-FP-CIT with homogeneous background in the whole brain region (Radiology Support Devices, Long beach, LA, USA) was utilized to evaluate the accuracy and also to calibrate the inter-institutional variations in multicenter evaluations in the EU [23] . The QSPECT reconstruction program was also evaluated using this phantom to assess the accuracy of the specific binding ratio (SBR) values [24] , by referring the values calculated from the true radioactivity in the striatum compartments relative to the whole-brain background concentration. Results demonstrated that the SBR values measured using QSPECT software agreed well with those determined from the true radioactivity concentrations. Variation was less than 1/3 of those with FBP reconstruction including the attenuation corrections. This suggested smaller inter-institutional/inter-vendor variations less than 1/3 with QSPECT when compared with FBP. This difference corresponds to the decline of both sensitivity and specificity from 97 to 78 % in our preliminary simulation study. It is therefore of a paramount importance to establish an accurate reconstruction methodology in order to provide a good diagnostic performance in clinical settings. Further careful evaluation is to be carried out.
QSPECT Program Packages
The program package of QSPECT uses a wrapper written in JAVA to run several programs written in C language for Microsoft Windows systems and also includes programs for reconstructing SPECT images, co-registering images, re-slicing, calculating functional images, and printing summary logs. Packages are prepared for the given data processing protocols for the given radiopharmaceuticals. Of those, a package to calculate the rest-and acetazolamide-CBF images with 123 I-IMP and the specific binding ratio (SBR) values with the distribution volume ratio (DVR) images with 123 I-FP-CIT have been utilized to support clinical diagnosis. The programs are also utilized to support clinical research.
Adequacy and Impact in Clinical Scans
Dopamine Transporter Function (SBR Quantitation)
Using 123 I-FP-CIT 2), which includes the TDCS scatter correction for the geometric projection data and the collimator aperture correction. It can be seen that the head contour was well delineated, as indicated by the red arrows. This is attributed to the carefully designed algorithm: the contour detection with the sine function constraint on the sonogram prior to the scatter correction. With the improved sensitivity and spatial resolution achieved using the triple head SPECT camera with a fan beam collimator designed for 123 I-nuclides, the collimator aperture model was effective to enhance and provide better striatum-to-background contrast with minimal enhancement of the background noise, though the SBR values essentially remained without changes. There may be lots of application areas where improved image quality can make contributions in clinical settings. The radiopharmaceutical 123 I-iomazenil (IMZ) is a radiopharmaceutical approved for clinical diagnosis to assess local neuronal damage in patients with epilepsy in Japan. There are also other applications to identify the presence of neuronal damage in the prefrontal areas of patients with neurological deficits after chronic ischemia (or Moyamoya disease) and traumatic brain injuries. We have aimed to highlight significantly damaged areas using 123 I-IMZ and SPECT in such patients by referring to normal patterns by means of 3D-SSP [1] [3, 5] . The challenge is to verify that identical data can be obtained from different SPECT systems installed in different institutions. Consistency is essential in order to utilize a common (normal) database rather than generating separate ones at each institution. At present, we have confirmed that a normal database for 123 I-IMZ generated at two independent institutions installed with different vendor SPECT systems showed smaller variations when QSPECT with AC, SC, and PC was utilized, as compared with vendor FBP reconstruction employing AC only. It was also observed that while vendor reconstruction provided different damage regions with the 3D-SSP analysis using the normal database generated at different institutions, only small differences could be seen between two sets of the normal database with QSPECT reconstruction. This is one area where the standardization of SPECT can make a significant contribution.
Rest-and Acetazolamide-CBF Using 123 I-IMP (The Dual-Table Autoradiography Method)
Extensive work has been conducted to establish and validate quantitative assessments of CBF at rest and after administration of acetazolamide with 123 I-IMP and dynamic SPECT using the QSPECT program packages (Fig. 2.7) . At present, the QSPECT software packages have been shown to be able to handle the data obtained from most SPECT cameras fitted with parallel beam collimators (see Table 2 .1). A total of more than 60,000 scans have been carried out in Japan between 2006 and January 2015, with 16,000 scans in 2014. The scans were mainly to assess the risk of hyper-perfusion after revascularization therapy in patients who are candidates for coronary artery stents and for coronary endarterectomy. The 123 I-IMP has a high first-pass extraction fraction and is capable of assessing quantitative CBF values for a physiologically wide range of blood flows [25, 26] . The object was to make the quantitative assessment of the rest-and acetazolamide-CBF images from scans obtained in a single session, with two injections of 123 I-IMP at 30 min intervals, to establish the ischemic status in the scans of each patient. A sophisticated compartment model was applied (called dualtable ARG) [27] to make it possible for the stress CBF images to be calculated using table look-up procedures without the need for image subtraction. This method appeared not to result in increases in statistical noise and more importantly was able to provide quantitative CBF images with minimal errors and only little inconsistency between the rest-and acetazolamide-CBF assessments. A number of studies were carried out to verify the method in clinical settings, funded by the Ministry of Health, Labour and Welfare Research Foundation from the year of 2007 for 3 years as follows:
(a) There was a fairly good intra-institutional reproducibility of rest-and acetazolamide-CBF images for the same patient, approximately 10 % with 44 patients at nine institutions [28] . (b) Inter-institutional reproducibility of rest-and acetazolamide-CBF images was approximately 6 % in nine patients on 18 data points [29] . An example case is shown in Fig. 2.8 . (c) Consistent results for rest and acetazolamide CBF at rest and after acetazolamide in healthy volunteers among three institutions (a total of 32 healthy volunteers) [22] . (d) Agreement with PET scan results both on relative distribution and absolute values was shown in one institution for five patients [28] . This examination is one good example that demonstrates the contribution of quantitative SPECT in clinical settings. Results of 3D-SSP shown in Fig. 2.8 are helpful in understanding the severity of ischemia and the risk status in patients with major artery occlusion or stenosis. This would also contribute to evaluate a number of therapeutic trials in the future.
Quality Control of the SPECT Scanner
It must be noted that standardization of the quantitative SPECT examination requires detailed self-defined protocols, including for the procedures of the administration, blood sampling, instructions to patients and patient movement, QC of SPECT devices, SPECT acquisition workflow, data pre-processing, and QSPECT reconstruction. Active feedback to deal with possible adverse events related to above procedures at clinical institutions appeared to be effective to maintain the reliability of the clinical scan findings. From July 2009 till May 2011, 139 cases were defined as potentially posing problems or possibly resulting in adverse events at 67 institutions. Claims were mostly unexpected low CFR values or unexpectedly low or high absolute CBF values. The software package was designed to keep a record of the complete calculation process, and among the data obtained in this manner, the tissue time-activity curve (tTAC) analysis for sequential short frame dynamic images and dynamic projections appeared to be helpful to identify the sources of errors. Of the 139 cases identified, 64 (42 %) did not suggest errors in the data or in the calculation process, as the observed CFR or small CBF values could be confirmed from results of the tTAC analysis, both in the dynamic reconstructed images as well as in the projection data. In other studies, the tTAC analysis was able to identify errors in the blood radioactivity concentrations (n ¼ 26), in the cross calibration procedures (n ¼ 25), in the IMP administration (n ¼ 17) due to the patient motion (n ¼ 11), and other factors including insufficient SPECT QC (n ¼ 11). Errors in the software program were not identified in any of the studies. The feedback provided in the information to the clinical institution was evaluated to be effective to improve the quality of the examination results. It is possible that the quality of reconstructed SPECT images is degraded by inaccurate reconstruction parameter settings in relation to the attenuation coefficients, accuracy of the head contour determination, inefficient statistical treatment, and also poor quality control (QC) of the SPECT device. It should be noted that there are no standard guidelines (like the NEMA standard) for reconstructed SPECT images, only for projection data. One contribution of the QSPECT reconstruction package is the ability to evaluate the image quality and accuracy on one domain with different systems. It was apparent that the engineers at the vendors should be encouraged to make effort to improve the quality of the reconstructed images rather than only on the projection data. Active feedback to the users at the clinical institutions is also essential to improve the quality of the examination in the quantitation. We also considered the FBP reconstruction with the scatter correction of Chang, for the scatter corrected-projection with TEW would be another possibility for standardization among different institutions. Systematic study has to be coordinated to validate the technique in multicenter settings.
Summary and Future Directions
The QSPECT package is able to reconstruct quantitative tomographic images from projection data acquired using commercial SPECT equipment. The adequacy was demonstrated with a series of phantom experiments. More importantly, the adequacy of images of biological functions and the use of stereotactic statistical analysis software were shown for some protocols in patient populations. Overall, this suggests the adequacy of using clinical SPECT devices for multicenter clinical studies. It is also possible to encourage the use of quantitative reconstruction with diagnosis-assisting software in clinical settings; this would enable an extension of the contribution of SPECT in evaluations of disease severity and so assist in decision making. Further systematic work should be designed to prove this concept for the various tracers in the various clinical settings.
